Specialty Drug Costs to Soar Again in 2018
The rate of spending increase on high-tech pharmaceuticals will top 17% for a second consecutive year, a study says.
How to Rein In the Soaring Costs of Specialty Drugs
The 420-employer National Business Group on Health recommends public-policy changes relating to the proliferating category of specialty drugs.
Specialty Drugs Drive Health Care Cost Trend
Health benefits costs are forecast to climb 5% next year, thanks in part to fast-rising prices for specialty pharmaceuticals.
Walgreens Buys Rite Aid for $9.4 Billion
The combination of two of the three largest U.S. drug store chains continues a wave of industry consolidation spurred by the Affordable Care Act.
Specialty Drugs Eat More of Health-Care Spending Pie
Thanks to a proliferation of high-cost drugs for complex conditions, pharmacy expenses outpace overall medical cost growth.